help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dixon, P. H.
Right arrow Articles by Thakker, R. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dixon, P. H.
Right arrow Articles by Thakker, R. V.
The Journal of Clinical Endocrinology & Metabolism Vol. 83, No. 10 3615-3623
Copyright © 1998 by The Endocrine Society


Original Studies

Mutational Analysis of PHEX Gene in X-Linked Hypophosphatemia1

Peter H. Dixon2, Paul T. Christie, Carol Wooding, Dorothy Trump3, Marvin Grieff, Ingrid Holm, Joseph M. Gertner, Jorg Schmidtke, Binita Shah, Nicholas Shaw, Colin Smith, Christina Tau, David Schlessinger, Michael P. Whyte and Rajesh V. Thakker

Medical Research Council Molecular Endocrinology Group, Medical Research Council Clinical Sciences Centre (P.H.D., P.T.C., C.W., D.T., R.V.T.), Imperial College School of Medicine, Hammersmith Hospital, London W12 ONN, United Kingdom; Renal Division (M.G.), Department of Molecular Microbiology and Center for Genetics in Medicine (D.S.), and Metabolic Research Unit, Shriners Hospital for Children and Division of Bone and Mineral Diseases (M.P.W.) ,Washington University School of Medicine (M.G.), St. Louis, Missouri 63110; Division of Genetics, Children’s Hospital (I.H.), Boston, Massachusetts 02115; Serono Laboratories, Inc. (J.M.G.), Norwell, Massachusetts 02061; Medizinische Hochschule Hannover, Abteilung Humangenetik, Zentrum Kinderheilkunde und Humangenetik (J.S.), Hannover D-30625, Germany; Childrens Medical Center of Brooklyn, Kings County Hospital Centre, University Hospital of Brooklyn (B.S.), Brooklyn, New York 11203-2098; Department of Growth and Endocrinology, The Birmingham Children’s Hospital National Health Service Trust (N.S.), Ladywood, Birmingham B16 8ET, United Kingdom; Alder Hey Children’s Hospital (C.S.), Liverpool, L12 2AR, United Kingdom; and Hospital de Pediatria Garrahan, Laboratoria de Metabolismo Calccio y Oseo, Endocrinologia (C.T.), Buenos Aeres, Argentina.

Address all correspondence and requests for reprints to: R. V. Thakker, Medical Research Council Molecular Endocrinology Group, Medical Research Council Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London W12 ONN, United Kingdom. E-mail: rthakker{at}rpms.ac.uk

Hypophosphatemic rickets is commonly an X-linked dominant disorder (XLH or HYP) associated with a renal tubular defect in phosphate transport and bone deformities. The XLH gene, referred to as PHEX, or formerly as PEX (phosphate regulating gene with homologies to endopeptidases on the X-chromosome), encodes a 749-amino acid protein that putatively consists of an intracellular, transmembrane, and extracellular domain. PHEX mutations have been observed in XLH patients, and we have undertaken studies to characterize such mutations in 46 unrelated XLH kindreds and 22 unrelated patients with nonfamilial XLH by single stranded conformational polymorphism and DNA sequence analysis. We identified 31 mutations (7 nonsense, 6 deletions, 2 deletional insertions, 1 duplication, 2 insertions, 4 splice site, 8 missense, and 1 within the 5' untranslated region), of which 30 were scattered throughout the putative extracellular domain, together with 6 polymorphisms that had heterozygosity frequencies ranging from less than 1% to 43%. Single stranded conformational polymorphism was found to detect more than 60% of these mutations. Over 20% of the mutations were observed in nonfamilial XLH patients, who represented de novo occurrences of PHEX mutations. The unique point mutation (a->g) of the 5'untranslated region together with the other mutations indicates that the dominant XLH phenotype is unlikely to be explained by haplo-insufficiency or a dominant negative effect.




This article has been cited by other articles:


Home page
Annals of Clinical & Laboratory ScienceHome page
J. Kim, K. H. Yang, J. S. Nam, J. R. Choi, J. Song, M. Chang, and K.-A Lee
A Novel PHEX Mutation in a Korean Patient with Sporadic Hypophosphatemic Rickets
Ann. Clin. Lab. Sci., January 1, 2009; 39(2): 182 - 187.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Makras, N. A. T. Hamdy, S. G. Kant, and S. E. Papapoulos
Normal Growth and Muscle Dysfunction in X-Linked Hypophosphatemic Rickets Associated with a Novel Mutation in the PHEX Gene
J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1386 - 1389.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Bai, D. Miao, D. Goltzman, and A. C. Karaplis
Early Lethality in Hyp Mice with Targeted Deletion of Pth Gene
Endocrinology, October 1, 2007; 148(10): 4974 - 4983.
[Abstract] [Full Text] [PDF]


Home page
JDRHome page
T. Onishi, R. Okawa, T. Ogawa, S. Shintani, and T. Ooshima
Phex Mutation Causes the Reduction of Npt2b mRNA in Teeth
Journal of Dental Research, February 1, 2007; 86(2): 158 - 162.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Sabbagh, G. Boileau, M. Campos, A. K. Carmona, and H. S. Tenenhouse
Structure and Function of Disease-Causing Missense Mutations in the PHEX Gene
J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2213 - 2222.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. R. Carpinelli, I. P. Wicks, N. A. Sims, K. O'Donnell, K. Hanzinikolas, R. Burt, S. J. Foote, M. Bahlo, W. S. Alexander, and D. J. Hilton
An Ethyl-Nitrosourea-Induced Point Mutation in Phex Causes Exon Skipping, X-Linked Hypophosphatemia, and Rickets
Am. J. Pathol., November 1, 2002; 161(5): 1925 - 1933.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. M. Jan De Beur and M. A. Levine
Molecular Pathogenesis of Hypophosphatemic Rickets
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2467 - 2473.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. T. Christie, B. Harding, M. A. Nesbit, M. P. Whyte, and R. V. Thakker
X-Linked Hypophosphatemia Attributable to Pseudoexons of the PHEX Gene
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3840 - 3844.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. A. Holm, A. E. Nelson, B. G. Robinson, R. S. Mason, D. J. Marsh, C. T. Cowell, and T. O. Carpenter
Mutational Analysis and Genotype-Phenotype Correlation of the PHEX Gene in X-Linked Hypophosphatemic Rickets
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3889 - 3899.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. Murer, N. Hernando, I. Forster, and J. Biber
Proximal Tubular Phosphate Reabsorption: Molecular Mechanisms
Physiol Rev, October 1, 2000; 80(4): 1373 - 1409.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
P S N ROWE
The molecular background to hypophosphataemic rickets
Arch. Dis. Child., September 1, 2000; 83(3): 192 - 194.
[Full Text] [PDF]


Home page
NEJMHome page
S. J. Scheinman, L. M. Guay-Woodford, R. V. Thakker, and D. G. Warnock
Genetic Disorders of Renal Electrolyte Transport
N. Engl. J. Med., April 15, 1999; 340(15): 1177 - 1187.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society